Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
65.82
+2.29 (3.60%)
Apr 6, 2026, 12:03 PM EDT - Market open
Inhibrx Biosciences Employees
As of December 31, 2025, Inhibrx Biosciences had 110 total employees, including 109 full-time and 1 part-time employees. The number of employees decreased by 51 or -31.68% compared to the previous year.
Employees
110
Change (1Y)
-51
Growth (1Y)
-31.68%
Revenue / Employee
$11,818
Profits / Employee
-$1,273,227
Market Cap
961.44M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 110 | -51 | -31.68% | 109 | 1 |
| Dec 31, 2024 | 161 | -11 | -6.40% | 156 | 5 |
| Mar 31, 2024 | 176 | - | - | 170 | 6 |
| Dec 31, 2023 | 172 | - | - | 166 | 6 |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,300 |
| Phathom Pharmaceuticals | 371 |
| UroGen Pharma | 291 |
| Xencor | 260 |
| Vor Biopharma | 154 |
| MapLight Therapeutics | 133 |
| Janux Therapeutics | 109 |
| ORIC Pharmaceuticals | 104 |
INBX News
- 17 days ago - Inhibrx Reports Fourth Quarter and Fiscal Year 2025 Financial Results - PRNewsWire
- 4 weeks ago - Inhibrx Announces Participation in Upcoming Scientific Conference - PRNewsWire
- 2 months ago - These 20 stocks are strong choices for momentum investors - Market Watch
- 3 months ago - Why Inhibrx's Recent Strength May Not Be Built to Last - Benzinga
- 3 months ago - Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program - PRNewsWire
- 5 months ago - Inhibrx Reports Third Quarter 2025 Financial Results - PRNewsWire
- 5 months ago - Inhibrx Announces Participation in Upcoming Scientific Conferences - PRNewsWire
- 5 months ago - Inhibrx shares surge after bone cancer drug slows disease progression in trial - Reuters